NCT05956860

Radial Access for Abdominopelvic Vascular Intervention

Evaluating the Safety and Efficacy of Radial Access for Abdominopelvic Vascular Intervention: a Prospective, Multicenter Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 1,143 (estimated)
• Sponsor: Zhongda Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the safety and efficacy of R.A.V.I.(radial access for abdominopelvic vascular intervention), and evaluate the feasibility and safety of repeated radial artery intervention

Detailed description

This is a prospective, multicenter clinical study with 1143 patients scheduled to enroll based on data from 10 hospitals for any abdominopelvic vascular intervention that can be performed via a radial approach。 The investigators conducted abdominopelvic vascular interventional therapy via radial artery approach according to the lesions and conditions of the subjects. All subjects underwent Barbeau tests before surgery to examine the flow traffic of the radial and ulnar arteries, and to measure the diameter of the radial artery (inner diameter) by Doppler ultrasound to evaluate its compatibility with the outer diameter of the vascular sheath. All enrolled subjects were followed up within 24 hours and 1 month after unsheathing to observe the clinical outcome of patients.

Conditions

• Vascular Access Device Complications

Interventions

Type	Name	Description
PROCEDURE	abdominopelvic vascular intervention through the radial artery access	According to the pathological changes and needs of the subjects (any abdominal and pelvic arterial intervention that can be performed through the radial artery access, including but not limited to: 1. hepatic intervention, such as transarterial chemoembolization (TACE), hepatic arterial infusion chemotherapy (HAIC), etc.; 2. Other visceral intervention, such as spleen, kidney, mesentery, etc.; 3. Pelvic intervention, such as uterine artery embolism, prostatic artery embolism, etc.; 4. Others, such as preoperative embolization of bone tumors (lumbar, sacral vertebra), etc.

Timeline

• Start date: 2023-08-07
• Primary completion: 2024-12-30
• Completion: 2025-12-30
• First posted: 2023-07-21
• Last updated: 2023-12-21

Locations

1 site across 1 country: China